G2B Pharma’s research is focused on the development of a needle-free alternative for epinephrine using the nasal delivery route. G2B is partnering in this effort with Shin Nippon Biological Laboratories of Japan, a leading developer of nasal spray devices and delivery systems. Our primary product candidate, G2B011, is a nasal spray formulation of epinephrine for the treatment of anaphylaxis. Anaphylaxis is a severe and life-threatening allergic reaction that affects tens of millions of people worldwide. Common causes of anaphylactic reactions include food allergies and bee stings. Epinephrine is the gold standard for treatment of anaphylaxis and is currently provided for self-administration by injection. The company believes that nasal administration offers an effective and more patient-friendly delivery route for this life-saving medication.
View Top Employees from G2B Pharma Inc| Website | http://g2bpharma.com |
| Revenue | $4.8 million |
| Funding | $235000 |
| Employees | 2 (0 on RocketReach) |
| Founded | 2008 |
| Address | 5 Presidio Ct, Corte Madera, California 94925, US |
| Phone | (415) 320-4391 |
| Technologies |
JavaScript,
HTML,
Microsoft Outlook
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceutical Development, Pharmaceuticals, Science and Engineering, Nasal Drug Delivery, Healthcare, Medical, Anaphylaxis Treatment, Health Care, Pharmaceutical |
| SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular G2B Pharma Inc employee's phone or email?
G2B Pharma Inc Questions
The G2B Pharma Inc annual revenue was $4.8 million in 2024.
G2B Pharma Inc is based in Corte Madera, California.
The NAICS codes for G2B Pharma Inc are [325, 32541, 3254, 32].
The SIC codes for G2B Pharma Inc are [2834, 283, 28].
